[Federal Register Volume 66, Number 202 (Thursday, October 18, 2001)]
[Notices]
[Page 52928]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-26215]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Program Project.
    Date: November 29, 2001.
    Time: 9:00 AM to 2:00 PM.
    Agenda: To review and evaluate grant applications.
    Place: Monarch Hotel, 2400 M St., NW., Washington, DC 20037.
    Contact Person: Khursheed Asghar, PhD, Chief, Basic Sciences 
Review Branch, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, 6001 Executive Boulevard, 
Room 3158, Msc 9547, Bethesda, MD 20892-9547, (301) 443-2620.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.78, Drug Abuse 
National Research Programs, National Institutes of Health, HHS)

    Dated: October 11, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-26215 Filed 10-17-01; 8:45 am]
BILLING CODE 4140-01-M